8 Photos and videos
1/8 ✨Thrilled to share that our paper is now online
@NatureBiotech
“Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors”
nature.com/articles/s41587-0…
(open access): rdcu.be/fmkQp
14
32
181
20,719
1/8 ✨Thrilled to share that our paper is now online
@NatureBiotech
“Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors”
nature.com/articles/s41587-0…
(open access): rdcu.be/fmkQp
14
32
181
20,719
8/8 💜 We especially thank the patients and their families for participating in the clinical trials and contributing tissue samples that made this research possible.
🏛️ We also thank our funding sources, including @theNCI, @AmericanCancer, @StanfordCancer, and @StanfordMIPS.
3
311
7/8 🙏 This project has been a long journey, and I am deeply grateful to my extraordinary postdoctoral mentors @EbenRosenthal and @GarryPNolan for their guidance and support throughout this work.
🤝 And to our wonderful collaborators @johnhickey22 @Max_Haist @Loloabn @ErnaForgoMD @marc_a_baertsch @xavi_r_c @nsvdb @poultsides and many others not on Twitter/X.
2
399
6/8 💡The SSP platform is broadly applicable to antibody-based therapeutics, including immune checkpoint inhibitors, antibody-drug conjugates, and multi-specific antibodies.
Incorporating SSP into early-phase clinical trials could advance the development of next-generation cancer therapeutics by uncovering mechanisms of response and resistance, guiding individualized dosing and identifying spatial biomarkers for participant stratification.
1
3
251
6/8 💡The SSP platform is broadly applicable to antibody-based therapeutics, including immune checkpoint inhibitors, antibody-drug conjugates, and multi-specific antibodies.
Incorporating SSP into early-phase clinical trials could advance the development of next-generation cancer therapeutics by uncovering mechanisms of response and resistance, guiding individualized dosing and identifying spatial biomarkers for participant stratification.
1
86
Please RT: The Lu Lab at Stanford is hiring a postdoc in Spatial Biology & Therapeutics. Comp bio, cancer bio, and cancer therapeutics backgrounds welcome. Available immediately; start date flexible. Details in attached ad. Apply: guolanlu@stanford.edu.
Lab website:med.stanford.edu/guolanlulab…
4
24
51
5,527
Congratulations Joe! Wonderful news for the department, and I’m excited to see your leadership, vision, and dedication guide us into the next chapter. 🎉
Apr 28
We are pleased to announce the appointment of Joseph Liao, MD, as the next Chair of the Department of Urology, effective August 1.
Read the full announcement from Dean Lloyd Minor: urology.stanford.edu/news/04…
@liaojoe1 @StanfordMed @AmerUrological
2
648
I’m excited to speak at the Advanced Tissue Imaging & Image Analysis Workshop at Kyoto University (Apr 13–15, 2026) on AI-powered image analysis for spatial biology. Fantastic lineup of speakers and hands-on training across multiplex imaging, 3D tissue imaging, and bioimage analysis. If you know students or postdocs working on spatial omics, imaging, or AI, please share.
Details & registration:
ccii.med.kyoto-u.ac.jp/en/ev…
#SpatialBiology #BioimageAnalysis #MultiplexImaging #Microscopy
5
28
2,763
Guolan Lu retweeted
Feb 23
Happy to share the very first manuscript from our lab. biorxiv.org/content/10.64898… Great collaborations with @AlbertHKimMDPhD @ahstegh @GuolanLu Feng Chen and Li Ding!
1
1
13
1,034